Literature DB >> 16935969

Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol.

K N Naresh1, I Lampert, R Hasserjian, D Lykidis, K Elderfield, D Horncastle, N Smith, W Murray-Brown, G W Stamp.   

Abstract

Specimens of bone marrow trephine biopsy (BMT) are transported and fixed in acetic acid-zinc-formalin fixative, decalcified in 10% formic acid-5% formaldehyde and processed with other specimens to paraffin-wax embedding. Sections, 1-microm-thick, are cut by experienced histotechnologists and used for haematoxylin and eosin, Giemsa, reticulin silver and other histological stains. Further, all immunohistochemical procedures used in the laboratory, including double immunostaining, can be used on these sections with no or minimal modifications. About 10,000 BMT specimens have been analysed using this procedure since 1997 and diseases involving the bone marrow have been classified successfully. More recently, standardised polymerase chain reaction-based analysis and mRNA in situ hybridisation studies have been conducted. Excellent morphology with good antigen, DNA and RNA preservation is offered by the Hammersmith Protocol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935969      PMCID: PMC1860463          DOI: 10.1136/jcp.2004.020610

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  54 in total

1.  The effect of decalcification and choice of fixative on histiocytic iron in bone marrow core biopsies.

Authors:  L DePalma
Journal:  Biotech Histochem       Date:  1996-03       Impact factor: 1.718

2.  A panel of antibodies for the immunostaining of Bouin's fixed bone marrow trephine biopsies.

Authors:  J L Gala; F Chenut; K B Hong; J Rodhain; P Camby; M Philippe; J M Scheiff
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

3.  The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.

Authors:  F Salomon-Nguyen; F Valensi; X Troussard; G Flandrin
Journal:  Leuk Res       Date:  1996 Nov-Dec       Impact factor: 3.156

4.  Use of methyl methacrylate resin for embedding bone marrow trephine biopsy specimens.

Authors:  D Blythe; N M Hand; P Jackson; S L Barrans; R D Bradbury; A S Jack
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

5.  Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.

Authors:  J D Hoyer; C Y Li; L T Yam; C A Hanson; P J Kurtin
Journal:  Am J Clin Pathol       Date:  1997-09       Impact factor: 2.493

6.  Immunohistochemical staining of plastic embedded bone marrow trephine biopsy specimens after microwave heating.

Authors:  W G McCluggage; S Roddy; C Whiteside; J Burton; H McBride; P Maxwell; H Bharucha
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

7.  Identification of granulocyte-macrophage colony stimulating factor receptor mRNA by non-isotopic in situ hybridization in bone marrow biopsies.

Authors:  F Roncaroli; R Dina; M Geuna; G Reato; R Ponti; G Palestro
Journal:  Haematologica       Date:  1994 Jul-Aug       Impact factor: 9.941

8.  Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.

Authors:  A Orazi; M Albitar; N A Heerema; S Haskins; R S Neiman
Journal:  Am J Clin Pathol       Date:  1997-03       Impact factor: 2.493

9.  Immunohistochemical analysis of decalcified paraffin-embedded human bone marrow biopsies with emphasis on MHC class I and CD34 expression.

Authors:  S A Loyson; L H Rademakers; P Joling; T M Vroom; J G van den Tweel
Journal:  Histopathology       Date:  1997-11       Impact factor: 5.087

10.  Detection of monoclonal B-cell populations in decalcified, plastic-embedded bone marrow biopsies with the polymerase chain reaction.

Authors:  F Fend; A Gschwendtner; E Gredler; J Thaler; O Dietze
Journal:  Am J Clin Pathol       Date:  1994-12       Impact factor: 2.493

View more
  9 in total

1.  Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Authors:  Shiri Weinstein; Itai A Toker; Rafi Emmanuel; Srinivas Ramishetti; Inbal Hazan-Halevy; Daniel Rosenblum; Meir Goldsmith; Avigdor Abraham; Ohad Benjamini; Osnat Bairey; Pia Raanani; Arnon Nagler; Judy Lieberman; Dan Peer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-23       Impact factor: 11.205

2.  Bone marrow metastasis of prostatic adenocarcinoma with post-treatment foamy-like changes: A diagnostic pitfall.

Authors:  Nuri Yigit; Julia Turbiner Geyer
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

3.  A Synoptic Reporting System to Monitor Bone Marrow Aspirate and Biopsy Quality.

Authors:  Roger S Riley; Paras Gandhi; Susan E Harley; Paulo Garcia; Justin B Dalton; Alden Chesney
Journal:  J Pathol Inform       Date:  2021-05-25

4.  Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples.

Authors:  Li Xiao; Song Luxi; Tao Ying; Liu Yizhi; Wu Lingyun; Pu Quan
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-28       Impact factor: 4.553

5.  Primary bone metastasis as first manifestation of an unknown primary tumour.

Authors:  Rafael García Carretero; Marta Romero Brugera; Noelia Rebollo-Aparicio; Liliam El Bouayadi Mohamed
Journal:  BMJ Case Rep       Date:  2015-09-03

6.  Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model.

Authors:  József Blazsek; Csaba Dobó Nagy; István Blazsek; Rita Varga; Bálint Vecsei; Pál Fejérdy; Gábor Varga
Journal:  Pathol Oncol Res       Date:  2009-03-07       Impact factor: 3.201

Review 7.  [Bone marrow biopsy: processing and use of molecular techniques].

Authors:  L Quintanilla-Martinez; M Tinguely; I Bonzheim; F Fend
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

8.  Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.

Authors:  Maria G Ioannou; Efstathios Stathakis; Andreas C Lazaris; Thomas Papathomas; Evangelos Tsiambas; George K Koukoulis
Journal:  Pathol Oncol Res       Date:  2008-06-14       Impact factor: 3.201

9.  Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study.

Authors:  Jasmita Dass; Sudheer Arava; Pravas Chandra Mishra; Amit Kumar Dinda; Hara Prasad Pati
Journal:  South Asian J Cancer       Date:  2019 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.